Has Andrew Carlson received payments from drug or device companies?

Yes. Drug and device makers reported $773 in general payments to Andrew Carlson across 46 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Carlson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Carlson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Carlson

Pediatrics · Albany, GANPI 1922059252

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $170 and has fallen 69.8% since, to $51 in 2025.

$773in general payments, 2019–2025

Across 46 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$136
Amgen$103
Corium, LLC$75
Tandem Diabetes Care, Inc.$64
Ironshore Pharmaceuticals Inc.$58
Ultragenyx Pharmaceutical Inc.$44
plus $293 from 15 others

$24,557in research payments, 2019–2025

Across 5 payments — averaging $4911.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi Pasteur Inc.$25K

What the payments were for

Food & beverage$773100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	9	$136
Amgen	7	$103
Corium, LLC	4	$75
Tandem Diabetes Care, Inc.	4	$64
Ironshore Pharmaceuticals Inc.	3	$58
Ultragenyx Pharmaceutical Inc.	2	$44
Biohaven Pharmaceutical Holding Company Ltd.	2	$39
Exact Sciences	2	$38
Cepheid	1	$22
Eisai Inc.	1	$20
Bayer	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$19
Hologic Sales And Service, LLC	1	$18
Dexcom, Inc.	1	$16
Almatica Pharma LLC	1	$16
AstraZeneca	1	$16
Biohaven Pharmaceuticals, Inc.	1	$15
Sanofi-aventis U.S. LLC	1	$14
Radius Health, Inc.	1	$14
Supernus Pharmaceuticals, Inc.	1	$13
Irhythm Technologies, Inc.	1	$13

How this compares

$773 in reported general payments places this provider in the 75th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia →

Other pediatrics in Albany

Amir AshrafiAtlanta$563K
Sandra ArmsteadLithonia$424K
Satheesh ChonatAtlanta$147K
Karen ZimowskiAtlanta$139K
F CantrellMarietta$129K
Iyabode Akinsanya-BeysolowAtlanta$103K
Lauren MiddlebrooksAtlanta$71K
Rebecca EmoryAtlanta$40K
Mark GriffithsAtlanta$34K
Kelly TickleAtlanta$29K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →